Google Search: Strattera 02/16/2003

Saved Google Search 02/16/2003 . . . courtesy of

[Note that many of these links expire after a few weeks]

Attention-deficit disorder can be lifelong problem
Kingsport Times News, TN - 11 Feb 2003
... In November of last year, the US Food and Drug Administration approved a new
prescription medication called Strattera, which was expected to arrive in ...

New ADHD treatment working for Idaho kid
KTVB, ID - 10 Feb 2003
... the solution parents are looking for. It’s called Strattera and was
approved in January. It treats ADHD symptoms differently than ...

Attention deficit disorder for adults
LA Times, CA - 09 Feb 2003
... The Indianapolis drug maker has been heavily marketing the drug Strattera,
also known as atomoxetine, for attention deficit/hyperactivity disorder. ...

The Facts on Strattera
Washington Post, DC - 04 Feb 2003
• Strattera is taken once a day; dose amounts are determined by
the patient's body weight. Washington psychiatrist Nora Galil ...

A New Choice for Treating ADHD
Washington Post, DC - 03 Feb 2003
... But if research and clinical trials prove correct, the newly released drug Strattera,
the object of the callers' questions, will help many children with ...

THE RATINGS GAME
CBS MarketWatch (subscription) - 03 Feb 2003
... steady progress with its manufacturing issues, that key pipeline drugs appear likely
to launch within the ensuing months, and that newly launched Strattera is ...

Indiana is 12th in study of ADHD
Indianapolis Star, IN - 03 Feb 2003
... and Concerta. Strattera, an ADHD drug made by Eli Lilly and Co., hit
the market this month and was not included in the survey. The ...

Lilly's And Schering's Blockbuster Hangovers
Forbes - 24 Jan 2003
... Strattera, a nonstimulant treatment for attention deficit disorder, and osteoporosis
drug Forteo have both been approved by the FDA and launched in the past ...

Strong quarter caps '02 for Lilly
Indianapolis Star, IN - 23 Jan 2003
... Two drugs hit the US market in the past few weeks: Strattera for attention-deficit
hyperactivity disorder and Forteo for osteoporosis. ...

Lilly Posts Profit, but Issues Warning
ABC News - 23 Jan 2003
... It won approval in November for two long-delayed medicines, Strattera
for attention deficit disorder and Forteo for osteoporosis. ...

Lilly Posts Profit, but Issues Warning
Reuters, UK - 23 Jan 2003
... It won approval in November for two long-delayed medicines, Strattera
for attention deficit disorder and Forteo for osteoporosis. ...

Lilly Posts 28 Percent Earnings Increase
Austin American Statesman, TX - 23 Jan 2003
... president and chief executive, said the drug maker has turned the corner with the
November approval of two drugs: Forteo, to treat osteoporosis, and Strattera ...

Lilly Posts 28 Percent Earnings Increase
ABC News - 23 Jan 2003
... president and chief executive, said the drug maker has turned the corner with the
November approval of two drugs: Forteo, to treat osteoporosis, and Strattera ...

Lilly Posts 28 Percent Earnings Increase
Kansas City Star, MO - 23 Jan 2003
... president and chief executive, said the drug maker has turned the corner with the
November approval of two drugs: Forteo, to treat osteoporosis, and Strattera ...

Lilly Earnings Rise, but Shares Fall
ABC News - 23 Jan 2003
... president and chief executive, said the drug maker has turned the corner with the
November approval of two drugs: Forteo, to treat osteoporosis, and Strattera ...

3 Drugmakers Post Gains, 2003 Seen Hard
ABC News - 23 Jan 2003
... He said Lilly should emerge strong after 2003 because of the recent approval of
its drug Strattera for attention deficit disorder and expected approval this ...

Lilly's And Schering's Blockbuster Hangovers
Forbes - 23 Jan 2003
... Strattera, a nonstimulant treatment for attention deficit disorder, and osteoporosis
drug Forteo have both been approved by the FDA and launched in the past ...

3 Drugmakers Post Gains, 2003 Seen Hard
Reuters, UK - 23 Jan 2003
... He said Lilly should emerge strong after 2003 because of the recent approval of
its drug Strattera for attention deficit disorder and expected approval this ...

Lilly Posts 28 Percent Earnings Increase
Austin American Statesman, TX - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Springfield News Sun, OH - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Seattle Times, WA - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
ABC News - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
San Jose Mercury News, CA - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Miami Herald, FL - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Sarasota Herald-Tribune, FL - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Lakeland Ledger, FL - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly Posts 28 Percent Earnings Increase
Seattle Post Intelligencer, WA - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat osteoporosis,
and Strattera, for attention deficit/hyperactivity disorder. ...

Lilly's Fourth Quarter Marks a Return to Quarterly Sales Growth ...
BusinessWire (press release) - 23 Jan 2003
... Strattera(TM) was approved by the US Food and Drug Administration (FDA) for the
treatment of attention-deficit hyperactivity disorder (ADHD) in children ...

New Lilly drug expects promising sales
WTHR, IN - 14 Jan 2003
Cathie's son took part in a clinical trial on the Eli Lilly and Company
drug Strattera. It hit pharmacy shelves Tuesday. Strattera ...

Lilly's new attention deficit drug Strattera hits US pharmacies
Ottawa Citizen, Canada - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's new attention deficit drug Strattera hits US pharmacies
Canada.com, Canada - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's Attention Deficit Drug Available
Sarasota Herald-Tribune, FL - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Lilly's new attention deficit drug hits pharmacies
Miami Herald, FL - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in November, said more
than 46000 pharmacies have stocked the drug and can begin filling prescriptions ...

Drugs: Relief from the Pain
BusinessWeek - 06 Jan 2003
... Eli Lilly & Co. (LLY ) is also likely to launch Strattera, for attention-deficit
hyperactivity disorder, and a new antidepressant called Cymbalta. ...

[Click here to subscribe to our NEW weekly newsletter!!]